Rena May

USPTO Granted Patents = 10 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 69(Granted Patents)

Location History:

Richmond, VA (US) (2013 - 2014)
Baltimore, MD (US) (2016 - 2023)

Company Filing History:

7 out of 512

Sloan-kettering Institute for Cancer Research

patents

3 out of 559

Memorial Sloan Kettering Cancer Center

patents

Years Active: 2013-2023

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11564988 - Single wall nanotube constructs and uses thereof (2023-01-31),

2. 11548924 - WT1 HLA class II-binding peptides and compositions and methods comprising same (2023-01-10),

3. 11414457 - Immunogenic WT-1 peptides and methods of use thereof (2022-08-16),

4. 10406236 - Single wall nanotube constructs and uses thereof (2019-09-10),

5. 10221224 - WT1 HLA class II-binding peptides and compositions and methods comprising same (2019-03-05),

6. 9629927 - Single wall nanotube constructs and uses thereof (2017-04-25),

7. 9265816 - Immunogenic WT-1 peptides and methods of use thereof (2016-02-23),

8. 9233149 - WT1 HLA class II—binding peptides and compositions and methods comprising same (2016-01-12),

9. 8765687 - WT1 HLA class II-binding peptides and compositions and methods comprising same (2014-07-01),

10. 8540965 - Single wall nanotube constructs and uses therefor (2013-09-24),

Title: Rena May: Innovator in Nanotechnology and Cancer Research

Introduction

Rena May is a prominent inventor based in Baltimore, MD, known for her significant contributions to the field of nanotechnology and cancer research. With a total of 10 patents to her name, she has developed innovative solutions aimed at improving cancer diagnostics and treatment.

Latest Patents

One of her latest patents is titled "Single wall nanotube constructs and uses thereof." This invention provides soluble single wall nanotube (SWNT) constructs that are functionalized with a variety of targeting moieties and payload molecules. These constructs can be utilized as diagnostic and therapeutic agents, particularly in the context of cancer treatment. Another notable patent is "WT1 HLA class II-binding peptides and compositions and methods comprising same." This invention focuses on WT1 peptides and methods for treating and inducing immune responses against WT1-expressing cancers.

Career Highlights

Rena May has worked at prestigious institutions such as the Sloan Kettering Institute for Cancer Research and the Memorial Sloan Kettering Cancer Center. Her work in these organizations has allowed her to advance her research and contribute to groundbreaking developments in cancer therapies.

Collaborations

Throughout her career, Rena has collaborated with esteemed colleagues, including David A. Scheinberg and Javier Pinilla-Ibarz. These partnerships have further enriched her research and innovation in the field.

Conclusion

Rena May's work exemplifies the intersection of nanotechnology and cancer research, showcasing her dedication to improving patient outcomes through innovative inventions. Her contributions continue to pave the way for advancements in cancer diagnostics and treatment.

This text is generated by artificial intelligence and may not be accurate.